![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
EJ Forsberg and RJ Miller
Serotonin release from rabbit enterochromaffin cells located in the mucosal epithelium of the small intestine was studied in vitro. Serotonin release from both the serosal and mucosal sides of the small intestine was measured. The addition of muscarinic but not nicotinic cholinergic agonists to the serosal medium resulted in a large but transient increase in serotonin release from the serosal but not the mucosal side of the intestine. Mucosal addition of these agents was ineffective. Serotonin release stimulated by the cholinergic agonist carbachol appeared to be dependent upon influx of extracellular Ca++ for the following reasons: 1) depletion of serosal Ca++ inhibited carbachol-stimulated release; 2) carbachol-stimulated serotonin release was blocked by the inorganic calcium channel blockers Co++, Ni++, Cd++, La and Gd; and 3) serosal serotonin release was increased by the Ca++ ionophore, ionomycin, and by Ba++. The addition of 8-bromoadenosine cyclic AMP or the phosphodiesterase inhibitor, 3-isobutyl-1- methylxanthine, to the serosal medium produced a sustained elevation of serosal serotonin release. 8-bromoadenosine-cyclic AMP-stimulated release was not blocked by depleting extracellular Ca++. Forskolin, a compound which stimulates adenylate cyclase, also stimulated serosal serotonin release. 8-bromoadenosine-cGMP had no effect on serotonin release. Somatostatin (10(-8)-10(-6) M) caused a dose-dependent inhibition of carbachol-stimulated serotonin release. Somatostatin (10(- 6) M) only partially inhibited serotonin release stimulated by 8- bromoadenosine-cyclic AMP, 3-isobutyl-1-methylxanthine and forskolin and had no effect on release stimulated by Ba++. The results suggest potential roles for both calcium and cyclic nucleotides in the regulation of serotonin release.
This article has been cited by other articles:
|
|
 |
|
  X. Qian, N. G. Moss, R. C. Fellner, and M. F. Goy Circulating Prouroguanylin Is Processed to Its Active Natriuretic Form Exclusively within the Renal Tubules Endocrinology, September 1, 2008; 149(9): 4499 - 4509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. G. Moss, R. C. Fellner, X. Qian, S. J. Yu, Z. Li, M. Nakazato, and M. F. Goy Uroguanylin, an Intestinal Natriuretic Peptide, Is Delivered to the Kidney as an Unprocessed Propeptide Endocrinology, September 1, 2008; 149(9): 4486 - 4498. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kidd, I. M. Modlin, B. I. Gustafsson, I. Drozdov, O. Hauso, and R. Pfragner Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants Am J Physiol Gastrointest Liver Physiol, August 1, 2008; 295(2): G260 - G272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P. Bertrand Real-time measurement of serotonin release and motility in guinea pig ileum J. Physiol., December 1, 2006; 577(2): 689 - 704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Fujimiya, H. Yamamoto, and A. Kuwahara Effect of VIP and PACAP on basal release of serotonin from isolated vascularly and luminally perfused rat duodenum Am J Physiol Gastrointest Liver Physiol, October 1, 1998; 275(4): G731 - G739. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
